Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$1.36 - $2.94 $122,400 - $264,600
-90,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$2.97 - $4.84 $267,300 - $435,600
90,000 New
90,000 $271,000
Q4 2020

Feb 16, 2021

SELL
$11.06 - $14.01 $3.07 Million - $3.9 Million
-278,020 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$10.26 - $14.55 $2.85 Million - $4.05 Million
278,020 New
278,020 $3.37 Million

Others Institutions Holding ATNX

About Athenex, Inc.


  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Pinz Capital Management, LP Portfolio

Follow Pinz Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pinz Capital Management, LP with notifications on news.